S-S5 BMT Tandem Luncheon Symposium: Emerging Agents in HCT

Track: BMT Tandem "Scientific" Meeting
Friday, February 3, 2012: 12:30 PM-1:30 PM
Elizabeth ABCDE (Manchester Grand Hyatt)
Chair:
John Koreth, MBBS, DPhil
Summary:

Symposium #5 (luncheon)

Emerging Agents in HCT
John Koreth, MBBS, DPhil, Dana-Farber Cancer Institute

Clinical Utility of Hypomethylating Agents Post-HCT
Marcos de Lima, MD, The University of Texas

Clinical Utility of HDAC Inhibitors Post-HSCT
Pavan Reddy, MD, University of Michigan